Saturday, June 4, 2016

New Study Led By John Theurer Cancer Center Researcher Demonstrates Potential Therapeutic Benefit Of TPI 287 With Bevacizumab In Treatment Of Aggressive Brain Cancer

… and often aggressive form of brain cancer.  
The study, "Phase 1 …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)